Previous Close | 1.1700 |
Open | 1.1900 |
Bid | 1.0100 x 2900 |
Ask | 1.1500 x 1200 |
Day's Range | 1.1000 - 1.1900 |
52 Week Range | 1.0000 - 9.5000 |
Volume | |
Avg. Volume | 936,001 |
Market Cap | 36.517M |
Beta (5Y Monthly) | 1.60 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.8520 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 17.83 |
Subscribe to Yahoo Finance Plus to view Fair Value for ERYP
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022 Cambridge, MA (U.S.) and Lyon (France), May 24, 2022 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the availability of the documents for its Annual General Meeting to be held on Friday, June 24, 2022. ERYTECH’s shareholders are her
ERYTECH to Present at the H.C. Wainwright Global Investment Conference Cambridge, MA (U.S.) and Lyon (France), May 17, 2022 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that its Chief Executive Officer, Gil Beyen, will present at the H.C. Wainwright Global Investment Conference. The conference will be held in a hybrid format from May 23-26
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2